Xilio Therapeutics, Inc.XLONASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
Studio
Year-over-Year Change

Free cash flow yield

Latest
-36.03%
↑ 85% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-238.28%
Historical baseline
PeriodValueYoY Change
2024-36.03%+92.1%
2023-456.96%-334.0%
2022-105.30%-15.4%
2021-91.25%+80.0%
2020-456.76%-61.2%
2019-283.38%-